ArticleClinical cancer research : an official journal of the American Association for Cancer Research2023

BBT-176, a Novel Fourth-Generation Tyrosine Kinase Inhibitor for Osimertinib-Resistant EGFR Mutations in Non-Small Cell Lung Cancer.

Sun Min Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.